NOW Aktie
WKN DE: A113R6 / ISIN: US67011P1003
|
24.07.2025 16:15:00
|
The 3 Things That Matter for Eli Lilly Now
Eli Lilly (NYSE: LLY) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong clinical and regulatory progress, as well as robust financial results, the drugmaker has routinely impressed Wall Street.Lilly has experienced a slowdown this year, and its shares have underperformed broader equities. Still, the company could turn things around and return to its market-beating ways, especially if it can execute effectively on several fronts.Let's discuss three critical areas of its business to pay close attention to right now.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NOW Inc When Issued
|
06.05.26 |
Ausblick: NOW mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
|
08.03.26 |
Latin America’s lithium triangle is now in the hands of the right (Financial Times) | |
|
07.03.26 |
Price is now the main ingredient in the office-lunch slop bowl (Financial Times) | |
|
07.03.26 |
Britain is now the home of the Middle Man (Financial Times) | |
|
05.03.26 |
Mildly dovish February ECB minutes are now stale (Financial Times) | |
|
05.03.26 |
Plunge in South Korean stocks saps an astounding market ride for now (Financial Times) | |
|
19.02.26 |
Ausblick: NOW gewährt Anlegern Blick in die Bücher (finanzen.net) | |
|
13.02.26 |
Politics is now driving the dollar (Financial Times) |
Analysen zu NOW Inc When Issued
Aktien in diesem Artikel
| Eli Lilly | 806,10 | -2,41% |
|
| NOW Inc When Issued | 11,10 | 0,00% |
|